Biomarkers of necrotising soft tissue infections: Aspects of the innate immune response and effects of hyperbaric oxygenation-the protocol of the prospective cohort BIONEC study

BMJ Open

Volumn 5, Issue 5, 2015, Pages

  Hansen, Marco Bo ^a   Simonsen, Ulf ^b   Garred, Peter ^a   Hyldegaard, Ole ^a  

^a Rigshospitalet   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FICOLIN; IMMUNOGLOBULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; N(G),N(G) DIMETHYLARGININE; NITRITE; PENTRAXIN 3; PROCALCITONIN; REACTIVE OXYGEN METABOLITE; IL6 PROTEIN, HUMAN; SERUM AMYLOID P;

ADULT; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITAL ADMISSION; HUMAN; HYPERBARIC OXYGEN; IMMUNOTHERAPY; INNATE IMMUNITY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MORTALITY; NECROTISING SOFT TISSUE INFECTION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PILOT STUDY; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; SOFT TISSUE INFECTION; TERTIARY CARE CENTER; TISSUE NECROSIS; BLOOD; FEMALE; HYPERBARIC OXYGEN THERAPY; IMMUNOLOGY; INTENSIVE CARE; LENGTH OF STAY; MALE; METABOLISM; NECROTIZING FASCIITIS; PROCEDURES; TREATMENT OUTCOME;

BIOMARKERS; C-REACTIVE PROTEIN; CRITICAL CARE; FASCIITIS, NECROTIZING; FEMALE; HUMANS; HYPERBARIC OXYGENATION; IMMUNITY, INNATE; INTERLEUKIN-6; LENGTH OF STAY; MALE; NITRITES; PROGNOSIS; PROSPECTIVE STUDIES; SERUM AMYLOID P-COMPONENT; SOFT TISSUE INFECTIONS; TREATMENT OUTCOME;

EID: 84930216570     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006995     Document Type: Article

References (46)

1. Hasham S, Matteucci P, Stanley PRW, et al. Necrotising fasciitis. BMJ 2005; 330: 830-3.
2. Sultan HY, Boyle AA, Sheppard N. Necrotising fasciitis. BMJ 2012; 345:e4274.
3. Golger A, Ching S, Goldsmith CH, et al. Mortality in patients with necrotizing fasciitis. Plast Reconstr Surg 2007; 119: 1803-7.
4. Muller B, Peri G, Doni A, et al. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med 2001; 29: 1404-7.
5. Al-Ramadi BK, Ellis M, Pasqualini F, et al. Selective induction of pentraxin 3, a soluble innate immune pattern recognition receptor, in infectious episodes in patients with haematological malignancy. Clin Immunol Orlando Fla 2004; 112: 221-4.
6. Sprong T, Peri G, Neeleman C, et al. Pentraxin 3 and C-reactive protein in severe meningococcal disease. Shock Augusta Ga 2009; 31: 28-32.
7. Mauri T, Bellani G, Patroniti N, et al. Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med 2010; 36: 621-9.
8. Huttunen R, Hurme M, Aittoniemi J, et al. High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort study. PLoS ONE 2011; 6:e17653.
9. Uusitalo-Seppälä R, Huttunen R, Aittoniemi J, et al. Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study. PLoS ONE 2013; 8:e53661.
10. Bastrup-Birk S, Skjoedt MO, Munthe-Fog L, et al. Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome. PLoS ONE 2013; 8: e73119.
11. Seller-Pérez G, Herrera-Gutiérrez ME, Lebrón-Gallardo M, et al. [Serum C-reactive protein as a marker of outcome and infection in critical care patients]. Med Clínica 2005; 125: 761-5.
12. Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis Off Publ Infect Dis Soc Am 2004; 39: 206-17.
13. Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006; 34: 1996-2003.
14. Reinhart K, Meisner M. Biomarkers in the critically ill patient: procalcitonin. Crit Care Clin 2011; 27: 253-63.
15. Kurt ANC, Aygun AD, Godekmerdan A, et al. Serum IL-1beta, IL-6, IL-8, and TNF-alpha levels in early diagnosis and management of neonatal sepsis. Mediators Inflamm 2007; 2007: 31397.
16. Panacek EA, Marshall JC, Albertson TE, et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med 2004; 32: 2173-82.
17. Heper Y, Akalin EH, Mistik R, et al. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 2006; 25: 481-91.
18. Wang CH, Gee MJ, Yang C, et al. A new model for outcome prediction in intra-abdominal sepsis by the linear discriminant function analysis of IL-6 and IL-10 at different heart rates. J Surg Res 2006; 132: 46-51.
19. Calandra T, Baumgartner JD, Grau GE, et al. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis 1990; 161: 982-7.
20. Riché F, Panis Y, Laisné MJ, et al. High tumor necrosis factor serum level is associated with increased survival in patients with abdominal septic shock: a prospective study in 59 patients. Surgery 1996; 120: 801-7.
21. Collighan N, Giannoudis PV, Kourgeraki O, et al. Interleukin 13 and inflammatory markers in human sepsis. Br J Surg 2004; 91: 762-8.
22. Marchant A, Alegre ML, Hakim A, et al. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol 1995; 15: 266-73.
23. El-Maghraby SM, Moneer MM, Ismail MM, et al. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies. J Pediatr Hematol Oncol 2007; 29: 131-6.
24. Fujishima S, Sasaki J, Shinozawa Y, et al. Serum MIP-1 alpha and IL-8 in septic patients. Intensive Care Med 1996; 22: 1169-75.
25. Patel RT, Deen KI, Youngs D, et al. Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 1994; 81: 1306-8.
26. Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164: 396-402.
27. De Werra I, Jaccard C, Corradin SB, et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997; 25: 607-13.
28. Skovgaard N, Gouliaev A, Aalling M, et al. The role of endogenous H2S in cardiovascular physiology. Curr Pharm Biotechnol 2011; 12: 1385-93.
29. Li L, Bhatia M, Moore PK. Hydrogen sulphide-a novel mediator of inflammation? Curr Opin Pharmacol 2006; 6: 125-9.
30. Li L, Bhatia M, Zhu YZ, et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J Off Publ Fed Am Soc Exp Biol 2005; 19: 1196-8.
31. Lin HC, Wan FJ, Wu CC, et al. Hyperbaric oxygen protects against lipopolysaccharide-stimulated oxidative stress and mortality in rats. Eur J Pharmacol 2005; 508: 249-54.
32. Niu KC, Huang WT, Lin MT, et al. Hyperbaric oxygen causes both antiinflammation and antipyresis in rabbits. Eur J Pharmacol 2009; 606: 240-5.
33. Yu X, Li YG, He XW, et al. Hyperbaric oxygen reduces inflammatory response in acute pancreatitis by inhibiting NF-kappaB activation. Eur Surg Res Eur Chir Forsch Rech Chir Eur 2009; 42: 130-5.
34. Yamashita M, Yamashita M. Hyperbaric oxygen treatment attenuates cytokine induction after massive hemorrhage. Am J Physiol Endocrinol Metab 2000; 278: E811-16.
35. Buras JA, Stahl GL, Svoboda KK, et al. Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of NOS. Am J Physiol Cell Physiol 2000; 278: C292-302.
36. Buras JA, Holt D, Orlow D, et al. Hyperbaric oxygen protects from sepsis mortality via an interleukin-10-dependent mechanism. Crit Care Med 2006; 34: 2624-9.
37. Yang BK, Vivas EX, Reiter CD, et al. Methodologies for the sensitive and specific measurement of S-nitrosothiols, iron-nitrosyls, and nitrite in biological samples. Free Radic Res 2003; 37: 1-10.
38. Aamand R, Dalsgaard T, Ho YCL, et al. A NO way to BOLD? Dietary nitrate alters the hemodynamic response to visual stimulation. NeuroImage 2013; 83: 397-407.
39. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-55.
40. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-6.
41. Sjövall F, Morota S, Asander Frostner E, et al. Cytokine and nitric oxide levels in patients with sepsis-temporal evolvement and relation to platelet mitochondrial respiratory function. PLoS ONE 2014; 9:e97673.
42. Mian AI, Aranke M, Bryan NS. Nitric oxide and its metabolites in the critical phase of illness: rapid biomarkers in the making. Open Biochem J 2013; 7: 24-32.
43. Hersch M, Scott JA, Izbicki G, et al. Differential inducible nitric oxide synthase activity in circulating neutrophils vs. mononuclears of septic shock patients. Intensive Care Med 2005; 31: 1132-5.
44. Dhillon SS, Mahadevan K, Bandi V, et al. Neutrophils, nitric oxide, and microvascular permeability in severe sepsis. Chest 2005; 128: 1706-12.
45. Mitaka C, Hirata Y, Yokoyama K, et al. Relationships of circulating nitrite/nitrate levels to severity and multiple organ dysfunction syndrome in systemic inflammatory response syndrome. Shock Augusta Ga 2003; 19: 305-9.
46. Strand OA, Leone A, Giercksky KE, et al. Nitric oxide indices in human septic shock. Crit Care Med 2000; 28: 2779-85.